A Specific High-Protein Weight Loss Program Does Not Impair Renal Function in Patients Who Are Overweight/Obese.
Anne-Sophie TrucheJean-François TimsitOdile FabreRémy LegrandPhilippe ZaouiPublished in: Nutrients (2022)
Although high-protein diets appear to be the most efficient way to lose weight, concerns may arise about their innocuity on renal function. The objective of this study is to assess the impact of a weight loss program on renal function. A multicentric cohort-based study was performed using the RNPC© French national weight loss program. Patients with at least two creatinine measurements at the beginning of the program and at the end of the weight loss phase between 1 January 2016 and 1 July 2021 were included. Renal function was assessed by Modification of Diet in Renal Disease (MDRD) equation-based estimated glomerular filtration rate (eGFR). From 4394 patients with two creatinine measurements included, 1579 (35.9%) had normal eGFR (MDRD 90-120 mL/min/1.73 m 2 ), 210 (4.8%) had hyperfiltration (MDRD > 120 mL/min/1.73 m 2 ), 2383 (54.2%) had chronic kidney disease (CKD) grade 2 (MDRD 60-90 mL/min/1.73 m 2 ), and 221 (5.0%) had CKD grade 3 (MDRD 30-60 mL/min/1.73 m 2 ). Multivariable analyses showed no eGFR change for patients in initial CKD grade 2, normal eGFR and hyperfiltration, and a significant increase in CKD grade 3. The RNPC© program avoids renal function impairment during the two first phases, regardless of the initial eGFR.
Keyphrases
- weight loss
- chronic kidney disease
- end stage renal disease
- small cell lung cancer
- epidermal growth factor receptor
- bariatric surgery
- quality improvement
- tyrosine kinase
- roux en y gastric bypass
- gastric bypass
- glycemic control
- weight gain
- obese patients
- newly diagnosed
- peritoneal dialysis
- protein protein
- uric acid
- metabolic syndrome
- type diabetes
- body mass index
- amino acid
- small molecule
- binding protein
- insulin resistance
- patient reported outcomes